{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:43:29Z","timestamp":1792194209869,"version":"4.4.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2006,5,12]],"date-time":"2006-05-12T00:00:00Z","timestamp":1147392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2006,5,12]],"date-time":"2006-05-12T00:00:00Z","timestamp":1147392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1111\/j.1365-2133.2006.07329.x","type":"journal-article","created":{"date-parts":[[2006,5,12]],"date-time":"2006-05-12T08:43:17Z","timestamp":1147423397000},"page":"261-266","source":"Crossref","is-referenced-by-count":111,"title":["Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion"],"prefix":"10.1093","volume":"155","author":[{"given":"C.","family":"Assaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bagot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Duvic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gniadecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Knobler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ranki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Schwandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,5,12]]},"reference":[{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB1|cit1","first-page":"5S23","article-title":"Algorithme th\u00e9rapeutique des lynphomes T cutan\u00e9s","volume":"132","author":"Bachelez","year":"2005","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1365-2133.2003.05698.x","article-title":"Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas","volume":"149","author":"Whittaker","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1517\/14728214.10.2.381","article-title":"Emerging drugs in cutaneous T-cell lymphomas","volume":"10","author":"Dummer","year":"2005","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB4|cit4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2006.01.025","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome","author":"Trautinger","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB5|cit5","first-page":"581","article-title":"Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma","volume":"137","author":"Duvic","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1200\/JCO.2001.19.9.2456","article-title":"Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results","volume":"19","author":"Duvic","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJM199904083401404","article-title":"Central hypothyroidism associated with retinoid X receptor-selective ligands","volume":"340","author":"Sherman","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB8|cit8","first-page":"481","article-title":"The thyrotrope-restricted isoform of the retinoid-X receptor-gamma1 mediates 9-cis-retinoic acid suppression of thyrotropin-beta promoter activity","volume":"11","author":"Haugen","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0021-9150(98)90209-X","article-title":"Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention","volume":"140","author":"Wood","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","author":"Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP)","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB11|cit11","unstructured":"National Institutes of Health. National Cholesterol Education Program Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Full Report Publication no. 02-5125 2002. http:\/\/www.nhlbi.nih.gov\/guidelines\/cholesterol\/atp3_rpt.htm"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1067\/mjd.2002.124607","article-title":"Optimizing bexarotene therapy for cutaneous T-cell lymphoma","volume":"47","author":"Talpur","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1056\/NEJMp030069","article-title":"The Mediterranean diet and mortality - olive oil and beyond","volume":"348","author":"Hu","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0026-0495(03)00260-9","article-title":"The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia","volume":"52","author":"Jenkins","year":"2003","journal-title":"Metabolism"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7326\/0003-4819-142-9-200505030-00007","article-title":"The effect of a plant-based diet on plasma lipids in hypercholesterolemic adults: a randomized trial","volume":"142","author":"Gardner","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1001\/jama.289.18.2379","article-title":"Relationship of changes in physical activity and mortality among older women","volume":"289","author":"Gregg","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/bmj.38415.644155.8F","article-title":"Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study","volume":"330","author":"Trichopoulou","year":"2005","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.CIR.99.6.779","article-title":"Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study","volume":"99","author":"De Lorgeril","year":"1999","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3816\/CLM.2003.n.006","article-title":"Etiology, diagnosis, and treatment recommendations for central hypothyroidism associated with bexarotene therapy for cutaneous T-cell lymphoma","volume":"3","author":"Sherman","year":"2003","journal-title":"Clin Lymphoma"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJM199908123410707","article-title":"Drug treatment of lipid disorders","volume":"341","author":"Knopp","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/hrt.74.1.14","article-title":"Long-term safety of statin-fibrate combination treatment in the management of hypercholesterolaemia in patients with coronary artery disease","volume":"74","author":"Feher","year":"1995","journal-title":"Br Heart J"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0002-9149(05)80034-7","article-title":"Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage","volume":"76","author":"Smit","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0002-9149(98)00040-X","article-title":"Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia","volume":"81","author":"Ellen","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00003088-200544030-00005","article-title":"Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs","volume":"44","author":"Zhou","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB25|cit25","first-page":"4","article-title":"Overview of drug interactions modulated by cytochrome P450","volume":"26","author":"Brown","year":"2001","journal-title":"US Pharmacist"},{"key":"10.1111\/j.1365-2133.2006.07329.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.290.11.1500","article-title":"Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme","volume":"290","author":"Markowitz","year":"2003","journal-title":"JAMA"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2006.07329.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2006.07329.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2006.07329.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:17:28Z","timestamp":1676366248000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/155\/2\/261\/6637216"}},"subtitle":["Minimizing side-effects of bexarotene in CTCL"],"short-title":[],"issued":{"date-parts":[[2006,5,12]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07329.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5,12]]}}}